Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
Document Type
Journal Article
Publication Date
7-1-2018
Journal
Oncogene
Volume
37
Issue
29
Inclusive Pages
3981-3997
DOI
10.1038/s41388-018-0238-8
Keywords
Autocrine Communication; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Imidazoles; Immunotherapy; Interleukin-11; Janus Kinase 2; Ovarian Neoplasms; Platinum; Prognosis; Proto-Oncogene Proteins c-fos; Pyrazoles; Pyridazines; Reactive Oxygen Species; Signal Transduction
APA Citation
Zhou, W., Sun, W., Yung, M., Dai, S., Cai, Y., Chen, C., Meng, Y., Lee, J., Braisted, J., Xu, Y., Southall, N., Shinn, P., Huang, X., Song, Z., Chen, X., Kai, Y., Cai, X., Li, Z., Hao, Q., Cheung, A., Ngan, H., Liu, S., Barak, S., Hao, J., Dai, Z., Tzatsos, A., Peng, W., Pei, H., Han, Z., Chan, D., Zheng, W., & Zhu, W. (2018). Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.. Oncogene, 37 (29). http://dx.doi.org/10.1038/s41388-018-0238-8
Peer Reviewed
1